Addus Targets Q1 2027 AccentCare Close, 13% Adjusted EBITDA Margin

The roughly $275 million deal is expected to add about $280 million in annualized revenue, pending customary regulatory approvals.

BeCrypto News shows a short excerpt and links to the publisher. The full report belongs to TokenPost.